Ground Swell Capital LLC Purchases New Position in Protalix BioTherapeutics, Inc. (NYSE:PLX)

Ground Swell Capital LLC acquired a new position in shares of Protalix BioTherapeutics, Inc. (NYSE:PLX) in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 62,234 shares of the company’s stock, valued at approximately $73,000. Ground Swell Capital LLC owned approximately 0.08% of Protalix BioTherapeutics at the end of the most recent quarter.

Separately, Virtu Financial LLC bought a new stake in Protalix BioTherapeutics during the 1st quarter worth approximately $198,000. Institutional investors and hedge funds own 16.53% of the company’s stock.

Protalix BioTherapeutics Stock Performance

Shares of PLX opened at $1.02 on Wednesday. The stock has a fifty day moving average price of $1.04 and a two-hundred day moving average price of $1.17. The company has a market cap of $74.78 million, a price-to-earnings ratio of 25.50 and a beta of 0.70. Protalix BioTherapeutics, Inc. has a 52-week low of $0.82 and a 52-week high of $1.90.

Protalix BioTherapeutics (NYSE:PLX) last issued its quarterly earnings results on Wednesday, August 14th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.02 by ($0.05). The company had revenue of $13.47 million for the quarter, compared to analyst estimates of $12.50 million. Protalix BioTherapeutics had a negative return on equity of 45.15% and a negative net margin of 38.62%. During the same quarter last year, the company earned ($0.07) EPS. As a group, research analysts predict that Protalix BioTherapeutics, Inc. will post 0.06 EPS for the current fiscal year.

Protalix BioTherapeutics Company Profile

Protalix BioTherapeutics, Inc, a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally.